Department of Surgery, CUHK
INTRANET EVENTS NEWS
CLINICAL SERVICES
HEPATO-BILIARY & PANCREATIC SURGERY UPPER GASTROINTESTINAL & METABOLIC SURGERY COLORECTAL SURGERY VASCULAR SURGERY PLASTIC, RECONSTRUCTIVE & AESTHERIC SURGERY NEUROSURGERY PAEDIATRIC SURGERY & PAEDIATRIC UROLOGY UROLOGY CARDIOTHORACIC SURGERY PRIVATE SERVICES
RESEARCH
CLINICAL RESEARCH BASIC SCIENCE RESEARCH
EDUCATION
UNDERGRADUATE RESEARCH POSTGRADUATE
ABOUT US
PEOPLE DIVISIONS & CENTRES


Professor WAN Song    
萬松

Professor
MD, FRCS (Eng), FACC

Cardiothoracic Surgery
(852) 3505 2629
swanadd this for spam@add this for spamsurgery.cuhk.edu.hk
N-7352-2016
0000-0002-9394-1672


Biography

Song Wan is currently Professor and Honorary Advisor in Cardiothoracic Surgery, the Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong. He is a Fellow of Royal College of Surgeons of England, American College of Cardiology, Hong Kong College of Cardiology, and College of Surgeons of Hong Kong. His clinical and research interests include reconstructive valve surgery and prevention of vein graft failure. To date, he has published more than 200 peer reviewed articles and 18 book chapters.

Professor Wan is a Councilor of Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) and Chairman of ASCVTS Education Committee. He is member of 12 learned professional bodies, such as American Association for Thoracic Surgery (AATS) and Society of Thoracic Surgeons (STS). He has been awarded Visiting Professorship at 10 leading medical schools in China (including Taiwan) as well as in USA. Professor Wan is an Assistant Editor of Heart Surgery Forum and an editorial board member of 14 international referred journals, including Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, and Asian Cardiovascular and Thoracic Annals. He also serves as a member of AATS Education Committee, AATS Foundation Asian Scholarship Committee, and STS Workforce on International Education.

Research Interests

  • Valve reconstruction and minimally invasive cardiac surgery
  • Vein graft research for coronary revascularization
  • Surgical history

Additional Information

BOOK EDITOR:
Wan S, Yim APC, eds. Cardiothoracic surgery in China: past, present, and future. Chinese University Press: Hong Kong, 2007

Selected Publications

  1. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997;112:676-692
  2. Wan S, Yim APC, Wong CK, Arifi AA, Yip JHY, Ng CSH, Waye MMY, Lam CWK. Expression of FHL2 and cytokine messenger RNAs in human myocardium after cardiopulmonary bypass. Int J Cardiol 2002;86:265-272
  3. Wan S, Yim APC, Johnson JL, Shukla N, Angelini GD, Smith FCT, Dashwood MR, Jeremy JY. The endothelin-1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts. J Thorac Cardiovasc Surg 2004;127:1317-1322
  4. Wan S, George SJ, Nicklin SA, Yim APC, Baker AH. Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts. Mol Ther 2004;9:689-698
  5. Wan S, Shukla N, Angelini GD, Yim APC, Johnson JL, Jeremy JY. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: A comparison with aspirin and morpholinosydnonimine (SIN-1). J Thorac Cardiovasc Surg 2007;134:1033-9
  6. George SJ, Wan S, Hu J, Johnson JL, MacDonald R, Baker AH. Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation 2011;124 [11 Suppl]:S135-S142
  7. Hu J, Liu J, Kwok MWT, Wong RHL, Huang Y, Wan S. Bone morphogenic protein-4 contributes to venous endothelial dysfunction in diabetic patients undergoing coronary revascularization. Ann Thorac Surg 2013; 95:1331–1339
  8. Wan S, Lee AP, Jin CN, Wong RH, Chan HM, Ng CS, Wan IY, Underwood MJ. The choice of mitral annuloplastic ring - beyond "surgeon's preference". Ann Cardiothorac Surg 2015;4:261-265
  9. Wan S, Lee AP, Attaran S, Yu PS, Au SS, Kwok MW, Lau RW, Wong RH, Wan IY, Ng SK, Underwood MJ. Mitral valve repair using a semirigid ring: patient selection and early outcomes. Asian Cardiovasc Thorac Annals 2016;24:647-652
  10. Zhang J, Sheng J, Dong L, Xu Y, Yu L, Liu Y, Huang XR, Wan S, Lan HY, Wang HS. Cardiomyocyte-specific loss of RMP causes myocardial dysfunction and heart failure. Cardiovasc Res 2019;115:1617-1628
  11. Wan S, Liu J. Commentary: Strength at the Cutting Edge. JTCVS Techniques 2020;2:58-9
  12. Wan S, Liu J. Decode a ticking time-bomb. [Editorial] J Thorac Dis 2020;12:4598-4601
  13. Wan S. Commentary: There is never “best,” only “better”. J Thorac Cardiovasc Surg 2021;161:e211-2
  14. Wan S. Mitral valve surgery at the oriental crossroad. [Editorial] Asian Cardiovasc Thorac Annals 2020;28:357-359
  15. Fan Y, Wan S, Wong RH, Lee AP. Atrial functional mitral regurgitation: mechanisms and surgical implications. Asian Cardiovasc Thorac Ann 2020; 28: 421–426
  16. Ho AMH, Norman P, Wan S, Saha T, Mizubuti GB. Understanding the fragility index in experimental clinical studies: an example using the meta analysis of compression-only vs. conventional CPR in out-of-hospital cardiac arrest. Can J Emerg Med 2020;22:633-636
  17. Wan S. Commentary: Out of Africa’s unmet needs. J Thorac Cardiovasc Surg 2021;162:1730-1731
  18. Huang J, Pu Y, Zhang H, Xie L, He L, Zhang CL, Cheng CK, Huo Y, Wan S, Chen S, Huang Y, Lau CW, Wang L, Xia Y, Huang Y, Luo JY. KLF2 mediates the suppressive effect of laminar flow on vascular calcification by inhibiting endothelial BMP/SMAD1/5 signaling. Circ Res 2021;129:e87–e100. DOI: 10.1161/CIRCRESAHA.120.318690
  19. Chow SC, Wan S. Commentary: Should prophylactic tricuspid annuloplasty be routinely performed? If so, how? The jury is still out. JTCVS Open 2021;7:139-40
  20. Wei X, Jiang DS, Wan S. Cardiovascular epidemiological research in China: A wake-up call no one can afford to ignore. The Lancet Regional Health–Western Pacific 2021;17:100308, doi: https://doi.org/10.1016/j.lanwpc.2021.100308
  21. Wan S, Hu J. Commentary: Following the game-changers: Are we on the right track now? J Thorac Cardiovasc Surg 2022;163:624-625, DOI: https://doi.org/10.1016/j.jtcvs.2020.06.070
  22. Qin YY, Huang XR, Zhang J, Wu W, Chen J, Wan S, Yu XY, Lan HY. Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction. Mol Ther 2022;30:881-897, doi: https://doi.org/10.1016/j.ymthe.2021.10.005
  23. Wan S, Wei X, Meng X. Commentary: Repairing the rheumatic mitral valve –Know the enemy and know yourself! J Thorac Cardiovasc Surg 2022;(in press) DOI: https://doi.org/10.1016/j.jtcvs.2020.08.029
  24. Hu J, Lee AP, Wei X, Cheng ZY, Ho AMH, Wan S. Update on surgical repair in functional mitral regurgitation. J Card Surg (published on 24 June 2021) DOI: https://doi.org/10.1111/jocs.15771
  25. Lim K, Wan S. Commentary: Looking into the crystal ball: will a clinical SYNTAX score help the heart team? J Thorac Cardiovasc Surg (in press) doi: https://doi.org/10.1016/j.jtcvs.2022.02.040

BACK

BACK



Copyright © 2022. All Rights Reserved. Department of Surgery, The Chinese University of Hong KongCUHK

C O N T A C T   U S